Section Arrow
VINC.NASDAQ
- Vincerx Pharma
Quotes are at least 15-min delayed:2024/05/13 11:10 EDT
Last
 0.7485
-0.054 (-6.73%)
Day High 
0.8189 
Prev. Close
0.8025 
1-M High
1.04 
Volume 
205.74K 
Bid
0.75
Ask
0.7687
Day Low
0.7417 
Open
0.807 
1-M Low
0.6607 
Market Cap 
23.70M 
Currency USD 
P/E -- 
%Yield
10-SMA 0.85 
20-SMA 0.87 
50-SMA 3.52 
52-W High 9.3722 
52-W Low 0.61 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.89/-2.03
Enterprise Value
25.04M
Balance Sheet
Book Value Per Share
0.38
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NVAXNovavax13.852+4.972+55.99%-- 
DNAGinkgo Bioworks Holdings0.8667+0.1058+13.90%-- 
ACIUAC Immune SA2.9875+0.6775+29.33%-- 
TVGNTevogen Bio Holdings1.0795+0.095+9.65%-- 
JAGXJaguar Health0.2717-0.0204-6.98%-- 
Quotes are at least 15-min delayed:2024/05/13 11:10 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADCplatform.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.